Controlled Human Infection Models for Schistosomiasis in Uganda (360G-Wellcome-209337_Z_17_Z)

£36,507

Our goal is to establish a controlled human infection model (CHIM) for schistosomiasis in Uganda, with a view to advancing vaccine development for this important parasitic infection. The objective of this proposal is to engage with, and inform, relevant stakeholders in Uganda about controlled human infection models through A visit to Leiden. Four to five key Ugandan personnel will visit Leiden University Medical Centre where the CHIM for schistosomiasis has been established to observe procedures. A stakeholder meeting in Uganda. Key stakeholders will be invited to a 2.5 day meeting to learn about CHIMs, and to discuss ethical, regulatory and practical procedures in relation to an outline proposal to establish the model in Uganda.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 36507
Applicant Surname Elliott
Approval Committee Internal Decision Panel
Award Date 2017-09-30T00:00:00+00:00
Financial Year 2016/17
Grant Programme: Title Discretionary Award - Vaccines
Internal ID 209337/Z/17/Z
Lead Applicant Prof Alison Elliott
Partnership Value 36507
Planned Dates: End Date 2018-08-14T00:00:00+00:00
Planned Dates: Start Date 2017-08-15T00:00:00+00:00
Recipient Org: Country Uganda
Region International